BridgeMD
New treatment option for Cannabidiol Effects
Official title The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex
ClinicalTrials.gov ID: NCT06686914
What this study is testing
What is Cannabidiol (CBD) Oil 300mg?
Cannabidiol (CBD) Oil 300mg is an investigational medicine, being studied as a potential treatment for cannabidiol effects.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The objectives/purpose of this study are to comprehensively investigate the effects of non-prescription CBD on driving performance, drowsiness, sedation, and cognitive function in a large sample of healthy adults aged 18-30 years, with additional characterization of effects by dose and by sex, using a rigorous RCT design which will naturally mitigate confounding factors.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30. Healthy volunteers may be eligible.
You may be able to join if
- Possess a current drivers' license
- Driven a motor vehicle at least once in the past 30 days
- Able to read English
- Test negative for all substances on a urine drug test and complete a test drive to ensure the absence of simulation sickness
- Not taking any daily prescription medications (excluding birth control)
You likely can't join if
- Currently smoke, vape or use tobacco products, used CBD in the past 30 days
- Used illegal drugs in the past 30 days (e.g., cocaine/crack, heroin, methamphetamine, 3,4-methylenedioxy-methamphetamine, inhalants, phencyclidine...
- Are pregnant or lactating at time of study
See the full eligibility criteria
- Possess a current drivers' license
- Driven a motor vehicle at least once in the past 30 days
- Able to read English
- Test negative for all substances on a urine drug test and complete a test drive to ensure the absence of simulation sickness
- Not taking any daily prescription medications (excluding birth control)
- Not diagnosed with any serious chronic disease by a licensed healthcare provider (including but not limited to Alzheimer's and related dementias, Parkinson's disease or other neurodegenerative disorder, major depressive...
- Have an individual willing to drive them home after testing or be taken home by study staff after testing
- Currently smoke, vape or use tobacco products, used CBD in the past 30 days
- Used illegal drugs in the past 30 days (e.g., cocaine/crack, heroin, methamphetamine, 3,4-methylenedioxy-methamphetamine, inhalants, phencyclidine, lysergic acid diethylamide, psilocybin mushrooms, or marijuana)
- Are pregnant or lactating at time of study
The study team makes the final eligibility decision.
Where it's taking place
- Morgantown, West Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Morgantown, West Virginia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.